Sign in

CIK 0000925741

  • Non-accelerated filer
  • Smaller reporting company

BioCardia, Inc.

Sign in to watch
Ticker
BCDA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
232753988
Phone
+1 650-226-0123
Business address
320 SOQUEL WAY, SUNNYVALE, CA, 94085
Former names
Tiger X Medical, Inc., Cardo Medical, Inc., CLICKNSETTLE COM INC, NAM CORP
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 4 Open-market buy Director bought 398,400 shares at $1.25 ($498,000)
  7. 4 Open-market buy Director bought 288,000 shares at $1.25 ($360,000)
  8. 4 Open-market buy President and CEO bought 48,000 shares at $1.25 ($60,000)
  9. 4 Open-market buy President and CEO bought 700 shares at $1.83 ($1,281)
  10. 4 Open-market buy President and CEO bought 100 shares at $1.83 ($183)
  11. 4 Open-market buy President and CEO bought 400 shares at $1.75 ($700)
  12. 4 Open-market buy President and CEO bought 1,700 shares at $1.76 ($2,989)
  13. 4 Open-market buy Chief Financial Officer bought 4,819 shares at $2.08 ($9,999)
  14. 4 Open-market buy President and CEO bought 24,096 shares at $2.08 ($49,999)
  15. 4 Open-market buy Director bought 72,289 shares at $2.08 ($150,000)
  16. 4 Open-market buy Director bought 72,289 shares at $2.08 ($150,000)
  17. 4 Open-market buy President and CEO bought 100 shares at $2.21 ($221)
  18. 4 Open-market buy President and CEO bought 2,300 shares at an average $2.02 ($4,651)
  19. 4 Open-market buy President and CEO bought 400 shares at an average $2.57 ($1,028)
  20. 4 Open-market buy Director bought 13,123 shares at $1.91 ($24,999)

Page 3 of 23 · 442 filings